AERS. See Adverse Event Reporting System

AEs. See Adverse events

Agency for Healthcare Research and Quality (AHRQ), 9, 11, 19, 23, 25, 32, 48, 109, 335

overarching coordination, 121–123

AHRQ. See Agency for Healthcare Research and Quality

AIMS. See Australian Incident Monitoring System

AIMS Risk Assessment Index (RAI), 294

Alert message, 327

Alertness, 230

Alternative Summary Reporting-Medical Devices (ASR), 335

AMA. See American Medical Association

American Dental Association (ADA), 99

American Hospital Association, 117–118

American Medical Association (AMA), 106

American National Standards Institute (ANSI), 97, 137, 335

American Society for Testing and Materials (ASTM), 100, 335

AMI. See Acute myocardial infarction

Ancillary information, 219

ANSI. See American National Standards Institute

Applications, continuum of, 252–254

Applied research agenda, 192–197

dissemination, 196–197

knowledge generation, 192–195

tool development, 195–197

Applied Strategies for Improving Patient Safety, 157

ASC. See Accredited Standards Committee

ASR. See Alternative Summary Reporting-Medical Devices

Assertional knowledge, 327

Association for the Advancement of Medical Instrumentation (AAMI), 137

ASTM. See American Society for Testing and Materials

Audit procedures, 196–197

Australian Incident Monitoring System (AIMS), 335

Risk Assessment Index, 294

taxonomy from, 509–510

Authentication, 327

Automated surveillance, rules for detecting possible adverse drug events using, 207

Automated triggers

for adverse events, 327

for chart review, 205

increasing importance of, 221–222

for outpatient adverse events, 208

B

Blood Product Deviation Reporting System (BPD), 335

BPD. See Blood Product Deviation Reporting System

C

Case-based reasoning, 327

Case studies, 184–192, 262–263, 492–507

continuous quality improvement (CQI), 492–493

detected ADE rates, 187

detecting and preventing adverse drug events, 185–187

failure mode and effect analysis (FMEA), 496–497

hazard analyis and critical control points (HACCP), 493–494

hazard and operability studies (HAZOP), 494–495

healthcare failure mode and effect analysis (HFMEA), 498–499

major causes of adverse drug events, 187

postoperative infections, 188–190

probabilistic risk assessment (PRA), 499–501

root-cause analysis (RCA), 501–503

Six Sigma, 503–505

Toyota Production System (TPS), 505–507



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement